May 2016 The BioMelbourne Network Industry/Academia Working group was established to work toward a shared vision for Melbourne as a city with a rich culture of collaboration that fosters industry-academic engagement. The purpose of the group is to…
May 2016 The BioMelbourne Network Clinical/Industry Working Group was established to work toward a shared vision for Melbourne as a world leading location for clinical trials. The purpose of the group is to promote and support Melbourne as…
18 April 2016 It’s time to do things differently in Australia and be bolder in our commitment to diversity, says CEO of the BioMelbourne Network Dr Krystal Evans. SCIENCE MEETS BUSINESS Though Leadership Series. Click here for full…
April 2016 Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest…
April 2016 In April 2016, Dr Krystal Evans participated in a roundtable discussion on “Women in STEM and Entrepreneurship” in Canberra. The aim of this roundtable was to bring together key representatives from Government, industry, research and education to…
February 2016 The R&D tax incentive is a highly successful policy programme has helped many Australian biotechnology and medical technology businesses to undertake additional R&D activities and to successfully create innovative health care products for the global export…
September 2015 In September 2015, BioMelbourne Network welcomed the opportunity to contribute to the Medical Technology and Pharmaceuticals Discussion Paper produced by the Victorian Government’s Department of Economic Development, Jobs, Transport and Resources. This Paper formed part of…